IMUGENE LIMITED — Capital/Financing Update 2021

Jul 26, 2021

Market Announcement

==> picture [33 x 50] intentionally omitted <==

27 July 2021

==> picture [451 x 5] intentionally omitted <==

Imugene Limited (ASX: IMU) – Trading Halt

Description

The securities of Imugene Limited (‘IMU’) will be placed in trading halt at the request of IMU, pending it releasing an announcement. Unless ASX decides otherwise, the securities will remain in trading halt until the earlier of the commencement of normal trading on Thursday, 29 July 2021 or when the announcement is released to the market.

Issued by

Melissa Kostopoulos

Compliance Adviser, Listings Compliance (Melbourne)

Market Announcement 1/1 ASX Customer Service Centre 131 279 | asx.com.au

27 July 2021 ASX Limited

==> picture [117 x 42] intentionally omitted <==

Suite 804, Level 8 37 Bligh Street Sydney NSW 2000 www.imugene.com ABN: 99 009 179 551 Phone: +61 3 9824 5254

27 July 2021

Melissa Kostopoulos Compliance Adviser, Listings Compliance (Melbourne) ASX Compliance Pty Ltd 525 Collins Street, Melbourne, VIC. 3000

Via email: Melissa.Kostopoulos@asx.com.au TradingHaltsMelbourne@asx.com.au

Dear Melissa

Imugene Limited (ASX: IMU) TRADING HALT REQUEST

In accordance with ASX Listing Rule 17.1, Imugene Limited (ASX: IMU) (the Company ) hereby requests that its securities be placed into an immediate trading halt pending an announcement in relation to a capital raising.

The Company requests that trading in its securities be halted until after the expected announcement is made or until the market opens on Thursday, 29 July 2021, whichever is the earlier.

The Company is not aware of any reason why this trading halt request should not be granted.

Please contact me if you require any further information.

Yours sincerely

==> picture [58 x 45] intentionally omitted <==

Phillip Hains Company Secretary Imugene Limited

info@imugene.com

IMUGENE LIMITED ACN 009 179 551

WWW.IMUGENE.COM